(0.07%) 5 249.75 points
(0.03%) 39 652 points
(0.12%) 18 277 points
(0.37%) $78.55
(1.42%) $2.28
(-1.08%) $2 349.40
(-0.72%) $28.30
(0.09%) $1 008.10
(-0.08%) $0.928
(0.12%) $10.85
(-0.02%) $0.798
(-1.00%) $91.74
@ $35.28
Issued: 14 Feb 2024 @ 15:02
Return: 50.85%
Previous signal: Feb 13 - 12:37
Previous signal:
Return: 0.28 %
Live Chart Being Loaded With Signals
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications...
Stats | |
---|---|
Today's Volume | 211 163 |
Average Volume | 688 493 |
Market Cap | 3.00B |
EPS | $0 ( 2024-03-11 ) |
Next earnings date | ( $-0.600 ) 2024-06-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.140 (0.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Fairmount Funds Management Llc | Buy | 51 166 | Common Stock |
2024-01-29 | Fairmount Funds Management Llc | Sell | 892 529 | Common Stock |
2023-12-18 | Henderson Michael Thomas | Buy | 398 512 | Stock Option (Right to Buy) |
2023-07-13 | Fairmount Funds Management Llc | Buy | 1 992 734 | Common Stock |
2023-07-13 | Fairmount Funds Management Llc | Buy | 892 529 | Common Stock |
INSIDER POWER |
---|
47.16 |
Last 9 transactions |
Buy: 3 438 612 | Sell: 892 529 |
Volume Correlation
Apogee Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Apogee Therapeutics, Inc. Correlation - Currency/Commodity
Apogee Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.660 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.660 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.790 |
Financial Reports:
No articles found.
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators